Georgie Hudson is a Research Assistant at the National Institute for Health and Care Research (NIHR) Maudsley Biomedical Research Centre. She recently co-authored a paper, in the Journal of Mental Health that analysed stigma on Twitter during the COVID-19 pandemic from the viewpoint of mental health service users. In this blog, she discusses the findings of her research, how best to study this complex concept and the way in which social media discussions around mental health changed during the pandemic.
By
NIHR Maudsley BRC at 17 Aug 2022
A new study from researchers supported by the NIHR Maudsley Biomedical Research Centre has found “substantial and concerning” gaps in the level of care being provided to people with depression. It also warns that those able to access care are “stagnating” in a system that results in their illness persisting for longer than it should.
By
NIHR Maudsley BRC at 11 Jul 2022
Naghmeh Nikkheslat is a Senior Research Associate at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) who is working on a project funded by the NIHR Maudsley BRC to investigate the use of ketamine as a medication for depression. In this blog, she talks about her research into depression and the immune system and what we currently know about ketamine as an anti-inflammatory antidepressant in psychiatric emergencies.
By
NIHR Maudsley BRC at 10 Jan 2022
New research from King’s College London, in partnership with COMPASS Pathways and supported by NIHR Maudsley BRC, has established that psilocybin can be safely administered at doses of either 10mg or 25mg to up to six participants at the same time.
By
NIHR Maudsley BRC at 4 Jan 2022
A group of mental health experts from research, industry, regulatory bodies and with lived experience have proposed new agreed criteria to define the type of depression that current medications and therapies cannot treat effectively. The report aims to provide consistent definitions for future research, and especially for designing clinical trials for new medications, with the aim of helping to develop more tailored and effective treatments for people experiencing this difficult condition.
By
NIHR Maudsley BRC at 15 Dec 2021
